Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2025-04-24 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
监事会关于《公司2024年度内部控制自我评价报告》审核意见
Audit Report / Information Classification · 90% confidence The document is a supervisory board's review and opinion on the company's 2024 internal control self-evaluation report. It references regulatory guidelines and confirms the report's compliance and accuracy but does not contain the report itself or detailed financial data. The document is short (300 characters) and serves as an audit opinion or certification related to internal controls, which aligns with an Audit Report / Information filing rather than a full Annual Report or Interim Report. Therefore, the classification is AR (Audit Report / Information). FY 2024
2025-04-24 Chinese
2025年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2025 年第一季度报告" which translates to "2025 First Quarter Report". It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the first quarter of 2025. The document explicitly states it is a quarterly report and mentions it is unaudited. The length of the document (12,677 characters) and the presence of comprehensive financial statements confirm it is a substantive financial report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2025
2025-04-24 Chinese
2024年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2024 年年度报告摘要" which translates to "2024 Annual Report Summary". It contains detailed financial data for the year 2024, including accounting policy changes, quarterly financial data, shareholder information, business overview, management discussion on strategy, risks, and future outlook. The length of the document is substantial (over 14,000 characters), indicating it is not a mere announcement or summary notice but contains substantive financial and operational information. The content aligns with the characteristics of an Annual Report (10-K) as it covers company activity, financial performance, accounting policies, and management discussion for the full fiscal year. Therefore, the document should be classified as an Annual Report (10-K). FY 2024
2025-04-24 Chinese
2024年度监事会工作报告
Management Reports Classification · 95% confidence The document is titled as the "2024年度监事会工作报告" which translates to "2024 Supervisory Board Work Report". It details the supervisory board's activities, compliance with laws, internal control reviews, financial oversight, and governance matters for the year 2024. The content is a detailed report on the supervisory board's work and oversight rather than a general annual report or financial statement. It does not contain full financial statements or comprehensive financial performance data typical of an Annual Report (10-K) or Interim Report (IR). It is also not a simple announcement or certification but a substantive report on supervisory activities. This type of document fits best under the category of Management Reports (MDA), which includes management's detailed explanation of business trends, governance, and oversight activities.
2025-04-24 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the sixth meeting of the fifth board of directors of a company. It includes voting results on various company matters such as the annual general manager's report, the annual board report, the annual report, quarterly report, financial statements, profit distribution, related party transactions, financing applications, cash management, auditor appointment, accounting policy changes, capital reduction of subsidiaries, director and senior management remuneration, internal control self-assessment, and the proposal to convene the annual general meeting. The document repeatedly states that these matters will be submitted to the 2024 annual general meeting for approval. The document is not the annual report itself, nor the quarterly report, but a board meeting resolution announcement. It is a formal disclosure of board decisions and approvals, which fits the category of Board/Management Information (MANG). The document length is 5716 characters, which is sufficient for a detailed board meeting resolution announcement. Therefore, the classification is MANG with high confidence.
2025-04-24 Chinese
年度股东大会通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2024 Annual General Meeting (AGM) of 葵花药业集团股份有限公司, including the meeting date, agenda items, voting procedures, registration details, and proxy forms. It does not contain the actual annual report, financial statements, or results of the meeting, but rather the announcement and instructions for the upcoming AGM. The document length is about 4941 characters, which is consistent with a detailed meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2025-04-24 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.